Yes, regular insulin can be used to lower a blood glucose of 450 mg/dL in an adult.
Regular insulin is an appropriate and effective choice for treating a blood glucose of 450 mg/dL, though the route of administration depends on the clinical context. For severe hyperglycemia without diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS), subcutaneous regular insulin can be used. However, if the patient has DKA or HHS, continuous intravenous regular insulin is the preferred treatment 1, 2, 1, 2.
Route Selection Based on Clinical Presentation
For Hyperglycemia WITHOUT DKA/HHS:
- Subcutaneous regular insulin is appropriate for blood glucose of 450 mg/dL
- Can be given as correctional (sliding scale) doses initially
- If hyperglycemia persists (≥2 readings ≥180 mg/dL in 24 hours), add scheduled basal insulin 3
- Target glucose range: 100-180 mg/dL (5.6-10.0 mmol/L) for hospitalized patients 3
For DKA or HHS:
- Continuous IV regular insulin infusion is the treatment of choice 1, 2, 1, 2
- Initial bolus: 0.15 units/kg body weight IV
- Followed by continuous infusion: 0.1 units/kg/hour (typically 5-7 units/hour in adults)
- This should decrease plasma glucose at 50-75 mg/dL/hour 1, 2
Important Clinical Considerations
Before administering insulin, always check potassium levels. If potassium is <3.3 mEq/L, hold insulin and replace potassium first to avoid life-threatening hypokalemia 1, 2.
Dosing for Subcutaneous Regular Insulin:
For mild hyperglycemia management, a common approach is:
- 5-unit increments for every 50 mg/dL increase above 150 mg/dL
- For glucose of 450 mg/dL, this would be approximately 15-20 units subcutaneously 1, 2
- Reassess glucose every 2-4 hours 1
When to Use IV vs Subcutaneous:
The decision hinges on severity:
- IV route: DKA, HHS, critically ill patients, severe hyperglycemia with metabolic derangement 1, 2
- Subcutaneous route: Stable patients with hyperglycemia but no acidosis or severe dehydration 3
Rapid-Acting Insulin as an Alternative
While regular insulin works well, rapid-acting insulin analogues (aspart, lispro, glulisine) are also effective and may have advantages 4. They result in fewer severe hypoglycemic episodes (moderate-certainty evidence) compared to regular insulin 4. However, for a glucose of 450 mg/dL, either formulation is acceptable—the choice often depends on availability and institutional protocols 5.
Critical Pitfalls to Avoid
- Never give insulin if potassium <3.3 mEq/L without correcting it first 1
- Avoid sliding scale insulin alone as the sole long-term strategy—it leads to poor control and increased hypoglycemia risk 6
- Don't abruptly stop IV insulin when transitioning to subcutaneous—give basal insulin 2-4 hours before stopping the infusion to prevent rebound hyperglycemia 7, 3
- Monitor for hypoglycemia especially as glucose approaches target range
- Assess for underlying precipitants (infection, MI, medication non-adherence) that caused the hyperglycemia
Fluid Resuscitation Matters
For glucose of 450 mg/dL, particularly if the patient is dehydrated, initiate IV fluid resuscitation concurrently with insulin therapy 1, 2. Start with 0.9% normal saline at 15-20 mL/kg/hour (or 1-1.5 L in the first hour for adults). Insulin works more effectively when volume status is restored.